Injectable Scaffolds represent a cutting-edge approach in regenerative medicine, offering a versatile solution for tissue engineering and repair. These scaffolds, typically composed of biocompatible materials, can be injected directly into targeted areas of the body, providing a minimally invasive means to support tissue regeneration. The scaffolds serve as a three-dimensional framework that facilitates cell adhesion, proliferation, and differentiation, promoting the formation of new tissue. Common materials include biodegradable polymers, hydrogels, and nanofibrous structures. Injectable scaffolds find applications in various medical fields, such as orthopedics, cardiology, and dermatology, addressing tissue damage, degeneration, or injury. In orthopedics, they may aid in cartilage or bone regeneration, while in cardiology, they can support cardiac tissue repair following a heart attack. The injectability of these scaffolds allows for precise placement, enabling clinicians to target specific anatomical locations. Incorporating bioactive agents, growth factors, or cells into the scaffold enhances its regenerative potential. However, challenges include ensuring the scaffold's stability and controlling its degradation rate. The development of injectable scaffolds represents a promising frontier, bridging the gap between traditional tissue engineering approaches and clinical applications, offering a potential revolution in the treatment of various medical conditions.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy